ClinicalTrials.Veeva

Menu

the Diagnostic Value of Rigiscan Test (Nocturnal Penile Tumescence and Rigidity, NPTR) in Chinese Males

N

Nanjing University

Status

Unknown

Conditions

Erectile Dysfunction

Treatments

Device: Rigiscan test

Study type

Observational

Funder types

Other

Identifiers

NCT02573805
NPTR in 2015-09-24

Details and patient eligibility

About

The purpose of this study is to evaluate the diagnostic value of Rigiscan (nocturnal penile tumescence and rigidity, NPTR ) test in erectile dysfunction of Chinese males.

Full description

The Rigiscan test is used to evaluate the NPTR parameters. The "normal" NPTR parameter is provided by the Rigiscan manufacturer based on a clinical study on 500 American males. Original studies of NPTR parameters on Chinese males are warranted. On the other hand, during the past decades, several new NPTR parameters have been developed, like tip TAU (tip tumescence activity units), tip RAU (tip rigidity activity units), base TAU (base tumescence activity units), base RAU (base rigidity activity units), but their diagnostic values have been less evaluated. Basd on the these background, we determined to observe the clinical manifestation of these new parameters and to establish the "normal criteria" of NPTR parameters in Chinese males. This could be clinically beneficial in the differential diagnosis of organic and psychological erectile dysfunction.

Enrollment

1,000 estimated patients

Sex

Male

Ages

20 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. patients in a stable and heterosexual partnership with a fixed sexual partner for more than 6 months;
  2. age≥20 year;
  3. complete the validated International Index of Erectile Function (IIEF-5) questionnaire.

Exclusion criteria

  1. advanced age (≥65);
  2. pelvic trauma
  3. thyroid diseases
  4. metabolic diseases
  5. hypogonadism and other hormonal disorders
  6. sleep disorders
  7. penile deformities
  8. taking drugs that may interfere with erectile function.

Trial design

1,000 participants in 2 patient groups

erectile dysfunction group
Description:
International Index of Erectile Function (IIEF-5) questionnaire≥22 Rigiscan test are performed for two nights
Treatment:
Device: Rigiscan test
control group
Description:
International Index of Erectile Function (IIEF-5) questionnaire\<22 Rigiscan test are performed for two nights
Treatment:
Device: Rigiscan test

Trial contacts and locations

1

Loading...

Central trial contact

yutian dai, doctor; l zhu, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems